Asia Pacific Pharmaceutical Contract Manufacturing Market
完整報告名稱與涵蓋範圍
Asia Pacific Pharmaceutical Contract Manufacturing Market by Country and Forecast till 2035
報告摘要
The Asia Pacific Pharmaceutical Contract Manufacturing Market by Country and Forecast till 2035 report provides detailed country-level analysis across China, India, South Korea, Japan, Australia, and Singapore. India leads in small-molecule API synthesis and cost-effective finished dosage generic manufacturing, serving as the "pharmacy of the world."
China holds massive capacity in chemical intermediates, contract research (CRO), and expanding biologic manufacturing. South Korea stands out as a global leader in large-scale commercial biomanufacturing, while Singapore and Japan offer high-spec specialized fill-finish and cell therapy contract services. Country-specific pharma ecosystem strengths will drive sustained regional market growth through 2035.
授權報價
| Single User Price | $750 USD |
| Multi User Licence (up to 10 users) | $1,000 USD |
| Enterprisewide Price (Global Site License) | $1,250 USD |
目錄 Table of Contents
TABLE OF CONTENT
1.1 Overview 9
1.2 CHINA 12
1.3 INDIA 16
1.4 JAPAN 20
1.5 SOUTH KOREA 24
1.6 AUSTRALIA 28
1.7 REST OF ASIA PACIFIC 32
2 DATA CITATIONS 37
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 12
TABLE 2 CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2019-2035 (USD MILLION) 14
TABLE 3 CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2019-2035 (USD MILLION) 14
TABLE 4 CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY PHARMACEUTICAL FDF MANUFACTURING SERVICES, 2019-2035 (USD MILLION) 15
TABLE 5 CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SOLID DOSAGE FORMS, 2019-2035 (USD MILLION) 15
TABLE 6 CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY LIQUID & SEMI-SOLID DOSAGE FORMS, 2019-2035 (USD MILLION) 16
TABLE 7 CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY INJECTABLE DOSAGE FORMS, 2019-2035 (USD MILLION) 16
TABLE 8 CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY BIOLOGIC MANUFACTURING SERVICES, 2019-2035 (USD MILLION) 17
TABLE 9 CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY DRUG DEVELOPMENT SERVICES, 2019-2035 (USD MILLION) 17
TABLE 10 CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER, 2019-2035 (USD MILLION) 17
TABLE 11 INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2019-2035 (USD MILLION) 19
TABLE 12 INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2019-2035 (USD MILLION) 19
TABLE 13 INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY PHARMACEUTICAL FDF MANUFACTURING SERVICES, 2019-2035 (USD MILLION) 19
TABLE 14 INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SOLID DOSAGE FORMS, 2019-2035 (USD MILLION) 20
TABLE 15 INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY LIQUID & SEMI-SOLID DOSAGE FORMS, 2019-2035 (USD MILLION) 20
TABLE 16 INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY INJECTABLE DOSAGE FORMS, 2019-2035 (USD MILLION) 22
TABLE 17 INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY BIOLOGIC MANUFACTURING SERVICES, 2019-2035 (USD MILLION) 22
TABLE 18 INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY DRUG DEVELOPMENT SERVICES, 2019-2035 (USD MILLION) 22
TABLE 19 INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER, 2019-2035 (USD MILLION) 24
TABLE 20 JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2019-2035 (USD MILLION) 25
TABLE 21 JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2019-2035 (USD MILLION) 25
TABLE 22 JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY PHARMACEUTICAL FDF MANUFACTURING SERVICES, 2019-2035 (USD MILLION) 25
TABLE 23 JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SOLID DOSAGE FORMS, 2019-2035 (USD MILLION) 27
TABLE 24 JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY LIQUID & SEMI-SOLID DOSAGE FORMS, 2019-2035 (USD MILLION) 27
TABLE 25 JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY INJECTABLE DOSAGE FORMS, 2019-2035 (USD MILLION) 28
TABLE 26 JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY BIOLOGIC MANUFACTURING SERVICES, 2019-2035 (USD MILLION) 28
TABLE 27 JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY DRUG DEVELOPMENT SERVICES, 2019-2035 (USD MILLION) 28
TABLE 28 JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER, 2019-2035 (USD MILLION) 30
TABLE 29 SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2019-2035 (USD MILLION) 31
TABLE 30 SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2019-2035 (USD MILLION) 31
TABLE 31 SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY PHARMACEUTICAL FDF MANUFACTURING SERVICES, 2019-2035 (USD MILLION) 31
TABLE 32 SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SOLID DOSAGE FORMS, 2019-2035 (USD MILLION) 32
TABLE 33 SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY LIQUID & SEMI-SOLID DOSAGE FORMS, 2019-2035 (USD MILLION) 32
TABLE 34 SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY INJECTABLE DOSAGE FORMS, 2019-2035 (USD MILLION) 34
TABLE 35 SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY BIOLOGIC MANUFACTURING SERVICES, 2019-2035 (USD MILLION) 34
TABLE 36 SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY DRUG DEVELOPMENT SERVICES, 2019-2035 (USD MILLION) 34
TABLE 37 SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER, 2019-2035 (USD MILLION) 36
TABLE 38 AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2019-2035 (USD MILLION) 37
TABLE 39 AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2019-2035 (USD MILLION) 37
TABLE 40 AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY PHARMACEUTICAL FDF MANUFACTURING SERVICES, 2019-2035 (USD MILLION) 37
TABLE 41 AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SOLID DOSAGE FORMS, 2019-2035 (USD MILLION) 38
TABLE 42 AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY LIQUID & SEMI-SOLID DOSAGE FORMS, 2019-2035 (USD MILLION) 38
TABLE 43 AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY INJECTABLE DOSAGE FORMS, 2019-2035 (USD MILLION) 40
TABLE 44 AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY BIOLOGIC MANUFACTURING SERVICES, 2019-2035 (USD MILLION) 40
TABLE 45 AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY DRUG DEVELOPMENT SERVICES, 2019-2035 (USD MILLION) 40
TABLE 46 AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER, 2019-2035 (USD MILLION) 42
TABLE 47 REST OF ASIA PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2019-2035 (USD MILLION) 43
TABLE 48 REST OF ASIA PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2019-2035 (USD MILLION) 43
TABLE 49 REST OF ASIA PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY PHARMACEUTICAL FDF MANUFACTURING SERVICES, 2019-2035 (USD MILLION) 44
TABLE 50 REST OF ASIA PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SOLID DOSAGE FORMS, 2019-2035 (USD MILLION) 44
TABLE 51 REST OF ASIA PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY LIQUID & SEMI-SOLID DOSAGE FORMS, 2019-2035 (USD MILLION) 45
TABLE 52 REST OF ASIA PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY INJECTABLE DOSAGE FORMS, 2019-2035 (USD MILLION) 45
TABLE 53 REST OF ASIA PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY BIOLOGIC MANUFACTURING SERVICES, 2019-2035 (USD MILLION) 46
TABLE 54 REST OF ASIA PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY DRUG DEVELOPMENT SERVICES, 2019-2035 (USD MILLION) 46
TABLE 55 REST OF ASIA PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER, 2019-2035 (USD MILLION) 46
LIST OF FIGURES
FIGURE 1 ASIA-PACIFIC MARKET ANALYSIS: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, 2019-2035 (USD MILLION) 11
FIGURE 2 ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2025 & 2035 (USD MILLION) 12
FIGURE 3 ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE (%), BY COUNTRY, 2025 13
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們